RECALL RECORD — CLASS IRecall closedF-1464-2024/FDA enforcement

Crecelac Infant 0-12 Powdered Infant Formula with Iron 12.4 OZ Cans

What you need to know

Class I
  • What happened

    The firm has not submitted the required premarket notification, parents and caregivers should understand that the products have not been evaluated to determine whether they meet…

  • Health risk

    The product has a reasonable probability of causing serious adverse health consequences or death. Cronobacter bacteria can cause severe illness, especially in infants and premature babies.

  • Action required

    Do not eat the product. Check the lot and UPC codes below, then discard it or return it to the retailer for a refund. If you have already eaten it, monitor for symptoms and seek medical care if they are severe or persistent.

Recall closed · classified by the FDADistribution not listedMore food

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Match before you discard

Product identification

Source: FDA FOOD

Brand nameDairy Manufacturers, INC
Recalling firmDairy Manufacturers, INCProsper, TX, United States
UPC / barcodesNo UPC listed in the FDA enforcement record.
Lot / date codes
  • 24 039 1 CHE 352-1 02/09/2024 AUG/2025 24 062 1 CHE 352-1 03/08/2024 SEP/2025
Distribution area

Throughout Texas

United States

Quantity affected5376 cans
Recall initiationFDA report date: July 17, 2024
FDA recall numberF-1464-2024

Beyond the headline

The recall, in context

Dairy Manufacturers, INC initiated this food recall on May 24, 2024. The FDA enforcement report states: The firm has not submitted the required premarket notification, parents and caregivers should understand that the products have not been evaluated to determine whether they meet U.S. food safety and nutritional standards. Cronobacter spp. detected by FDA sampling. The FDA report lists distribution as: Throughout Texas.

The FDA enforcement report describes the reason as: The firm has not submitted the required premarket notification, parents and caregivers should understand that the products have not been evaluated to determine whether they meet U.S. food safety and nutritional standards. Cronobacter spp. detected by FDA sampling.

Crecelac Infant 0-12 Powdered Infant Formula with Iron 12.4 OZ Cans was made or distributed by Dairy Manufacturers, INC in Prosper, TX, United States. This page reflects FDA report F-1464-2024, dated July 17, 2024.

Why this is a Class I recall

Class I means the product has a reasonable probability of causing serious adverse health consequences or death. In this recall, cronobacter bacteria can cause severe illness, especially in infants and premature babies.

FDA definition

The product has a reasonable probability of causing serious adverse health consequences or death.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the lot and date codes against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Cronobacter

Symptoms to watch for

In infants, possible poor feeding, irritability, temperature changes, jaundice, grunting or seizures. In adults, fever and gastrointestinal symptoms may occur.

When symptoms may appear

The timing varies; infant infections can become serious quickly.

Higher-risk groups

Infants, especially premature or low-birth-weight babies, and immunocompromised people are at highest risk.

What to do now

  1. 1Do not feed the affected product to an infant or anyone in a high-risk group.
  2. 2If an infant has poor feeding, unusual irritability, fever or breathing problems, seek urgent medical care.
  3. 3Keep the packaging, contact the retailer or manufacturer for a refund, and follow the recall notice for safe disposal.

Powdered infant formula and infant-feeding products warrant extra caution.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the Crecelac Infant 0-12 Powdered Infant Formula with Iron 12.4 OZ Cans recall?

Dairy Manufacturers, INC recalled Crecelac Infant 0-12 Powdered Infant Formula with Iron 12.4 OZ Cans in an FDA Class I enforcement action reported as F-1464-2024. The firm has not submitted the required premarket notification, parents and caregivers should understand that the products have not been evaluated to determine whether they meet…

What should I do if I bought this product?

Do not eat the product. Check the lot and UPC codes below, then discard it or return it to the retailer for a refund. If you have already eaten it, monitor for symptoms and seek medical care if they are severe or persistent. Do not feed the affected product to an infant or anyone in a high-risk group. If an infant has poor feeding, unusual irritability, fever or breathing problems, seek urgent medical care. Keep the packaging, contact the retailer or manufacturer for a refund, and follow the recall notice for safe disposal.

Is the Dairy Manufacturers, INC recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record F-1464-2024. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Brand history

More recalls by Dairy Manufacturers, INC

View brand

Related alerts

Recent Cronobacter recalls

All alerts

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.